Glendora Digestive Disease Institute is a freestanding outpatient endoscopic facility specializing in colorectal cancer screening and the treatment of GI diseases and disorders. We have proudly served the Glendora, Calif., area since 2004. Our board-certified gastroenterologists provide high quality care in a friendly, relaxed setting.
Learn MoreGlendora Digestive Disease Institute is committed to ensuring that your experience with us is relaxed and worry-free, from consultation through recovery. To assist us, we ask that you read and comply with all guidelines.
At Glendora Digestive Disease Institute, your time is as valuable to us as it is to you. That's why we provide online access to a variety of forms that patients may complete before their visit. The following documents will help us expedite the check-in process for your appointment. Please take a moment to download and print the appropriate form(s).
Glendora Digestive Disease Institute accepts most major insurances. As a courtesy to you, we will bill your insurance carrier for you; however, we cannot tell you what your policy will cover. Since your insurance policy and coverage is between you and your carrier, we urge you to contact them prior to your procedure. You will be responsible for any co-pays and/or deductibles. We accept cash, check or credit card.
With our online bill pay option, you can securely make a payment for your service online with no hassles.
When you take a look at the statistics, it appears that irritable bowel syndrome (IBS) is the big problem no one wants to talk about. IBS is the most common functional gastrointestinal disorder, affecting 10-15 percent of people worldwide. Yet an estimate
Some people can manage their acid reflux symptoms by making lifestyle changes, such as losing extra weight or avoiding spicy foods. But for others, these modifications simply aren’t enough.
The colonoscopy is considered the most thorough and effective procedure for detecting and treating colon cancer. Just one exam can offer up to 10 years of protection against the third deadliest cancer in the United States.
Subscribe to our newsletter for updates and information.
